Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus

BACKGROUND: Stomatitis is a frequent dose limiting toxicity of everolimus, an approved therapy for patients with metastatic breast cancer. No randomized trials of a prophylactic measure to prevent mucositis have been reported. METHODS: We conducted a phase II, open-label trial in which patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Peddi, Parvin F., Tetef, Merry, Coluzzi, Paul, Arzoo, Karo K., Hu, Eddie H., Berkowitz, Maurice J., Chan, David, Moore, Dennis, Adams, Brad, Wang, Xiaoyan, Hurvitz, Sara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711222/
https://www.ncbi.nlm.nih.gov/pubmed/33299473
http://dx.doi.org/10.1177/1758835920967259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711222/
https://www.ncbi.nlm.nih.gov/pubmed/33299473
http://dx.doi.org/10.1177/1758835920967259

Ejemplares similares